Skip to main content
. Author manuscript; available in PMC: 2019 Nov 1.
Published in final edited form as: Eye Contact Lens. 2018 Nov;44(Suppl 2):S307–S313. doi: 10.1097/ICL.0000000000000463

Table 3.

Non-ocular pain conditions by dry eye (DE) status (mild or greater DE symptoms, DEQ5≥6, versus no symptoms,DEQ5<6)

No DE
symptoms
(n=139)
Mild or greater
DE symptoms
(n=94)
OR CI p Value
Primary central sensitization*
  Back pain, n (%) 24 (17%) 32 (34%) 2.47 1.34–4.56 <0.001
  Muscle pain, n (%) 10 (7%) 25 (27%) 4.63 2.10–10.22 <0.001
  Headaches, n (%) 25 (18%) 30 (32%) 2.14 1.16–3.95 0.02
  Tendonitis, n (%) 7 (5%) 5 (5%) 1.06 0.33–3.44 0.92
  Trigeminal neuralgia, n (%) 0 (0%) 1 (1%) -- -- 1.00
  TMJ pain, n (%) 0 (0%) 6 (6%) -- -- 1.00
  Fibromyalgia, n (%) 1 (1%) 1 (1%) 1.48 0.09–24.02 0.78
  Migraines, n (%) 18 (13%) 19 (20%) 1.70 0.84–3.45 0.14
Secondary central sensitization*
  Arthritis, n (%) 5 (4%) 18 (19%) 6.34 2.27–17.78 <0.001
  Chronic postsurgical pain, n (%) 5 (4%) 6 (6%) 1.83 0.54–6.17 0.33
  Diabetic neuropathy, n (%) 1 (1%) 1 (1%) 1.48 0.09–24.02 0.78
  Sciatica, n (%) 8 (6%) 5 (5%) 0.92 0.29–2.90 0.89
  Burn pain, n (%) 1 (1%) 3 (3%) 4.52 0.46–44.10 0.20

OR=odds ratio; CI=confidence interval; DEQ5, dry eye questionnaire 5; TMJ, temporomandibular joint pain

*

Classification from Yunus MB. Editorial review: an update on central sensitivity syndromes and the issues of nosology and psychobiology. CurrRheumatol Rev 2015;11:70–85.